Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
8,564,500
-
Total 13F shares
-
19,264,140
-
Share change
-
-301,518
-
Total reported value
-
$508,636,288
-
Put/Call ratio
-
238%
-
Price per share
-
$26.41
-
Number of holders
-
83
-
Value change
-
-$21,986,693
-
Number of buys
-
45
-
Number of sells
-
41
Institutional Holders of Atara Biotherapeutics, Inc. - Common Stock (ATRA) as of Q4 2015
As of 31 Dec 2015 Atara Biotherapeutics, Inc. - Common Stock (ATRA) had 83 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 19,264,140 shares of stock of the company.
Largest 10 holders included BAUPOST GROUP LLC/MA, FMR LLC, Redmile Group, LLC, UBS ASSET MANAGEMENT AMERICAS INC, EAGLE ASSET MANAGEMENT INC, BlackRock Fund Advisors, Arrowpoint Asset Management, LLC, Visium Asset Management, LP, BRIDGER MANAGEMENT, LLC, and STATE STREET CORP.
This table shows 83 institutional shareholders of the security as of 31 Dec 2015.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.